Viewing Study NCT06802757


Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2025-12-29 @ 10:39 PM
Study NCT ID: NCT06802757
Status: RECRUITING
Last Update Posted: 2025-06-17
First Post: 2025-01-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Posaconazole Plus Pembrolizumab and Chemotherapy vs Pembrolizumab and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer
Sponsor: Shandong Cancer Hospital and Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module